119 related articles for article (PubMed ID: 26971035)
1. Actylise treatment does not influence nitric oxide metabolites serum level.
Horecka A; Szpetnar M; Hordyjewska A; Babula D; Gołąb P; Kurzepa J
Pharmacol Rep; 2016 Jun; 68(3):598-600. PubMed ID: 26971035
[TBL] [Abstract][Full Text] [Related]
2. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
Gołąb P; Boguszewska-Czubara A; Kiełbus M; Kurzepa J
Neurol Neurochir Pol; 2014; 48(5):309-14. PubMed ID: 25440008
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study.
Kurzepa J; Szpetnar M; Hordyjewska A; Wątroba S; Gołąb P; Boguszewska-Czubara A
Neurol Res; 2015 Oct; 37(10):934-7. PubMed ID: 26005019
[TBL] [Abstract][Full Text] [Related]
4. Decreased nitric oxide serum level after pituitary adenoma resection.
Babula D; Horecka A; Luchowska-Kocot D; Kocot J; Kurzepa J
J Neurosurg Sci; 2020 Oct; 64(5):452-455. PubMed ID: 28945050
[TBL] [Abstract][Full Text] [Related]
5. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
Clark WM; Albers GW; Madden KP; Hamilton S
Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
[TBL] [Abstract][Full Text] [Related]
6. The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.
Harston GW; Sutherland BA; Kennedy J; Buchan AM
J Cereb Blood Flow Metab; 2010 Nov; 30(11):1804-16. PubMed ID: 20736961
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
Ringleb PA; Schellinger PD; Schranz C; Hacke W
Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
[TBL] [Abstract][Full Text] [Related]
9. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke.
Worthmann H; Martens-Lobenhoffer J; Joumaah M; Li N; Lichtinghagen R; Hecker H; Kielstein JT; Ehrenreich H; Bode-Böger SM; Weissenborn K
Stroke; 2013 Aug; 44(8):2128-33. PubMed ID: 23788583
[TBL] [Abstract][Full Text] [Related]
11. Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.
Bugnicourt JM; Duru C; Picard C; Godefroy O
Clin Ther; 2008 Sep; 30(9):1675-80. PubMed ID: 18840373
[TBL] [Abstract][Full Text] [Related]
12. Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology.
Barassi A; Corsi Romanelli MM; Pezzilli R; Damele CA; Vaccalluzzo L; Goi G; Papini N; Colpi GM; Massaccesi L; Melzi d'Eril GV
Andrology; 2017 Mar; 5(2):256-261. PubMed ID: 28178400
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activities in vitro.
Golab P; Kielbus M; Bielewicz J; Kurzepa J
Neurol Res; 2015 Jan; 37(1):9-13. PubMed ID: 24963695
[TBL] [Abstract][Full Text] [Related]
14. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
15. Plasma citrulline, arginine, nitric oxide, and blood ammonia levels in neonatal calves with acute diarrhea.
Gultekin M; Voyvoda H; Ural K; Erdogan H; Balikci C; Gultekin G
J Vet Intern Med; 2019 Mar; 33(2):987-998. PubMed ID: 30788867
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
17. Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.
Lu K; Xu X; Cui S; Wang F; Zhang B; Zhao Y
J Neurol Sci; 2015 Dec; 359(1-2):202-6. PubMed ID: 26671113
[TBL] [Abstract][Full Text] [Related]
18. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
19. l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans.
Bailey SJ; Blackwell JR; Lord T; Vanhatalo A; Winyard PG; Jones AM
J Appl Physiol (1985); 2015 Aug; 119(4):385-95. PubMed ID: 26023227
[TBL] [Abstract][Full Text] [Related]
20. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
